Potential of photodynamic therapy using polycationic photosensitizers in the treatment of lung cancer patients with SARS-CoV-2 infection and bacterial complications: Our recent experience.

Publication date: Feb 01, 2025

The problem of treating cancer patients with lung cancer has become more difficult due to the SARS-CoV-2 viral infection and concomitant bacterial lesions. The analysis shows that the photodynamic effect of long-wavelength polycationic photosensitizers suppresses the tumor process (including the destruction of cancer stem cells), SARS-CoV-2 coronavirus infection, Gram-positive and Gram-negative bacteria, including those that can cause pneumonia. Therefore, the photodynamic approach using such photosensitizers is promising for the development of an effective treatment method for patients with lung cancer, including those with SARS-CoV-2 infection and bacterial complications.

Concepts Keywords
Cancer Bacteria
Photosensitizers COVID-19
Pneumonia Humans
Therapy Lung cancer
Viral Lung Neoplasms
Photochemotherapy
Photodynamic therapy
Photosensitizing Agents
Photosensitizing Agents
polycations
Polyelectrolytes
Polyelectrolytes
SARS-CoV-2
SARS-CoV-2

Semantics

Type Source Name
disease MESH lung cancer
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH complications
disease MESH cancer
disease MESH viral infection
disease IDO process
disease MESH coronavirus infection
disease IDO bacteria
disease MESH pneumonia

Original Article

(Visited 1 times, 1 visits today)